Product
DBI-102
1 clinical trial
1 indication
Indication
HyperpigmentationClinical trial
A Randomized, Observer-Blinded, Vehicle-Controlled Study on the Safety and Efficacy of Twice Daily Application of Ruboxistaurin (DBI-102) Gel Vs.Vehicle Gel Vs. Hydroquinone Cream on Sun-Exposed and Sun-Protected Skin of AdultsStatus: Completed, Estimated PCD: 2023-03-07